(1) (a) The committee shall recommend placement of a substance in Schedule I if it
finds:

(i) that the substance has high potential for abuse; and

(ii) that an accepted standard has not been established for safe use in treatment for
medical purposes.

(b) The committee may recommend placement of a substance in Schedule I under
Section 58-37-4 if it finds that the substance is classified as a controlled
substance in Schedule I under federal law.

(2) (a) The committee shall recommend placement of a substance in Schedule II if it
finds that:

(i) the substance has high potential for abuse;

(ii) the substance has a currently accepted medical use in treatment in the United States,
or a currently accepted medical use subject to severe restrictions; and

(iii) the abuse of the substance may lead to severe psychological or physiological
dependence.

(b) The committee may recommend placement of a substance in Schedule II if it finds
that the substance is classified as a controlled substance in Schedule II under federal law.

(3) (a) The committee shall recommend placement of a substance in Schedule III if it
finds that:

(i) the substance has a potential for abuse that is less than the potential for substances
listed in Schedules I and II;

(ii) the substance has a currently accepted medical use in treatment in the United States;
and

(iii) abuse of the substance may lead to moderate or low physiological dependence or
high psychological dependence.

(b) The committee may recommend placement of a substance in Schedule III if it finds
that the substance is classified as a controlled substance in Schedule III under federal law.

(4) (a) The committee shall recommend placement of a substance in Schedule IV if it
finds that:

(i) the substance has a low potential for abuse relative to substances in Schedule III;

(ii) the substance has currently accepted medical use in treatment in the United States;
and

(iii) abuse of the substance may lead to limited physiological dependence or
psychological dependence relative to the substances in Schedule III.

(b) The committee may recommend placement of a substance in Schedule IV if it finds
that the substance is classified as a controlled substance in Schedule IV under federal law.

(5) (a) The committee shall recommend placement of a substance in Schedule V if it
finds that:

(i) the substance has low potential for abuse relative to the controlled substances listed in
Schedule IV;

(ii) the substance has currently accepted medical use in treatment in the United States;
and

(iii) the substance has limited physiological dependence or psychological dependence
liability relative to the controlled substances listed in Schedule IV.

(b) The committee may recommend placement of a substance in Schedule V under this
chapter if it finds that the substance is classified as a controlled substance in Schedule V under
federal law.

(6) The committee may recommend placement of a substance on a controlled substance
list if it finds that the substance has a potential for abuse and that an accepted standard has not
been established for safe use in treatment for medical purposes.